An ACT Government Website
Disclaimer
The content provided on this page is intended for use by health professionals. It is not tailored for the general public and should not be interpreted as personal medical advice. If you are not a healthcare professional and have concerns or questions regarding your health or a medical condition, we encourage you to consult your healthcare provider.

This page has information for registered pharmacists on applying for an opioid dependency treatment licence to dispense methadone, buprenorphine or buprenorphine/naloxone for the treatment of drug dependency.

Licence conditions

You must be a registered pharmacist.

You must make sure that the person the buprenorphine or methadone is administered to signs a written or electronic form to acknowledge:

  • the approved name and brand of medicine administered
  • the form, strength and quantity of medicine administered
  • the date the medicine is administered
  • that the medicine has been administered to that person.

Buprenorphine and methadone must be obtained on a complying purchase order.

Dispensing methadone, buprenorphine or buprenorphine or buprenorphine/naloxone must be in line with the National Guidelines for Medication Assisted Treatment of Opioid Dependence.

Dispensing of these medicines should comply with Opioid Maintenance Treatment in the ACT: Local Policies and Procedures [PDF 548kB].

You must complete training for the safe administration and dispensing of opioid maintenance treatment as outlined in the ACT Legislation Register.

Apply for a licence

Apply for an opioid treatment centre licence by downloading the licence application [PDF 301kB].